RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 86 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $5,062,000 | -51.0% | 234,482 | -50.1% | 1.64% | -44.0% |
| Q2 2019 | $10,329,000 | -7.0% | 469,482 | +15.9% | 2.92% | -26.8% |
| Q1 2019 | $11,102,000 | +3.3% | 405,026 | +1.3% | 3.99% | -19.1% |
| Q4 2018 | $10,752,000 | -47.1% | 400,000 | -42.6% | 4.94% | -26.0% |
| Q3 2018 | $20,329,000 | -9.9% | 696,903 | -3.5% | 6.66% | -13.4% |
| Q2 2018 | $22,567,000 | +467.0% | 721,903 | +261.0% | 7.69% | +366.2% |
| Q1 2018 | $3,980,000 | -21.7% | 200,000 | +14.3% | 1.65% | -53.7% |
| Q4 2017 | $5,086,000 | – | 175,000 | – | 3.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 810,000 | $19,845,000 | 8.20% |
| NEA Management Company, LLC | 4,912,306 | $108,316,000 | 5.41% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $46,403,000 | 3.57% |
| RA Capital Management | 5,471,067 | $134,041,000 | 2.86% |
| Samsara BioCapital, LLC | 345,293 | $8,460,000 | 1.97% |
| Altium Capital Management LP | 170,000 | $4,165,000 | 1.53% |
| Parkman Healthcare Partners LLC | 187,989 | $4,606,000 | 1.31% |
| Rock Springs Capital Management LP | 1,760,865 | $43,141,000 | 1.11% |
| EAM Investors, LLC | 198,699 | $4,868,000 | 1.06% |
| Prosight Management, LP | 80,000 | $1,960,000 | 1.05% |